Skip to main content
    P

    Profusa, Inc. Common Stock (PFSA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.41
    -0.04 (-9.44%)

    Market Cap: $271,330

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Profusa, Inc. Common Stock (PFSA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Profusa, Inc. Common Stock are Catheter Precision (VTAK), Safeplus International Holdings (BIPH) and Hyperfine (HYPR). By market cap, Profusa, Inc. Common Stock ranks 13th of the 13 companies on this page; Neuropace (NPCE) is the largest at $260.45M.

    Peer Comparison

    PFSA's ROIC of 220.0% is above the peer median of -52.0%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Profusa, Inc. Common Stock (PFSA)$271330N/AN/A0.0%220.0%0.0%0.00%
    Catheter Precision Inc. (VTAK)$286480N/AN/A0.0%N/A380.7%0.00%
    Safeplus International Holdings Limited (BIPH)$357540N/A0.3x0.0%N/A17.1%8.62%
    Hyperfine Inc (HYPR)$66.74MN/A3.4x-156.4%-52.0%73.4%0.00%
    Neuropace Inc (NPCE)$260.45MN/A2.9x-17.7%-16.7%-1.1%0.00%
    Sensus Healthcare Inc (SRTS)$38.27MN/A2.3x-88.4%N/A-68.7%0.00%
    GlucoTrack Inc (GCTK)$2.43MN/AN/A0.0%-6319.2%0.0%0.00%
    Trinity Biotech plc (TRIB)$4.96MN/AN/A-85.4%-14.3%-5.5%0.00%
    Nuwellis Inc (NUWE)$2.65MN/AN/A-125.6%N/A14.1%0.00%
    Microbot Medical Inc (MBOT)$65.73MN/A125.1x0.0%N/A0.0%0.00%
    Sera Prognostics Inc (SERA)$79.94MN/AN/A0.0%N/A162.5%0.00%
    Elutia Inc. (ELUT)$36.41M0.8x10.9x400.2%-111.1%-65.8%0.00%
    Modular Medical Inc (MODD)$18.71MN/AN/A0.0%N/A0.0%0.00%
    Peer median$27.56M0.8x3.1x0.0%-52.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Profusa, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Medical Devices; the other one is in Medical Instruments & Supplies.

    CompanyAboutPeers
    Catheter Precision Inc. (VTAK)Medical Devices
    Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals...
    Safeplus International Holdings Limited (BIPH)Medical Instruments & Supplies
    Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is headquartered in Pittsford, New York.
    Hyperfine Inc (HYPR)Medical Devices
    Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system...
    HYPR competitors
    Neuropace Inc (NPCE)Medical Devices
    NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
    NPCE competitors
    Sensus Healthcare Inc (SRTS)Medical Devices
    Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide.
    SRTS competitors
    GlucoTrack Inc (GCTK)Medical Devices
    GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes...
    GCTK competitors
    Trinity Biotech plc (TRIB)Medical Devices
    Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments...
    TRIB competitors
    Nuwellis Inc (NUWE)Medical Devices
    Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy.
    NUWE competitors
    Microbot Medical Inc (MBOT)Medical Devices
    Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting...
    MBOT competitors
    Sera Prognostics Inc (SERA)Medical Devices
    Sera Prognostics Inc. is a pioneering force in maternal-fetal health, focusing on cutting-edge diagnostic solutions designed to enhance pregnancy outcomes.
    SERA competitors
    Elutia Inc. (ELUT)Medical Devices
    Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes.
    ELUT competitors
    Modular Medical Inc (MODD)Medical Devices
    Modular Medical, Inc., a development-stage medical device company, focuses on the design...
    MODD competitors

    Frequently Asked Questions About PFSA

    Who are Profusa, Inc. Common Stock's main competitors?

    The companies most similar to Profusa, Inc. Common Stock include Catheter Precision (VTAK), Safeplus International Holdings (BIPH), Hyperfine (HYPR), Neuropace (NPCE) and Sensus Healthcare (SRTS), listed from the closest match.

    Who is Profusa, Inc. Common Stock's biggest competitor?

    Neuropace (NPCE) is the largest of the similar companies at $260.45M; Catheter Precision (VTAK) is the closest match by business profile, size, sector and industry.

    How does PFSA stock compare with its competitors?

    PFSA's net margin is 0.0% against a peer median of 0.0%.

    Which of Profusa, Inc. Common Stock's competitors pays a higher dividend?

    Profusa, Inc. Common Stock pays no dividend. Safeplus International Holdings (BIPH) has a higher forward dividend yield; Safeplus International Holdings (BIPH) has the highest at 8.62%.

    Is Profusa, Inc. Common Stock bigger than its competitors?

    No. Profusa, Inc. Common Stock is 13th by market cap among the 13 companies on this page; the largest is Neuropace (NPCE) at $260.45M.